METABOLOMIC IN ANTIPHOSPHOLIPID SYNDROME STRATIFIED PATIENTS ACCORDING TO THEIR THROMBOTIC RISK

被引：0
|
作者：
Lopez-Pedrera, C. [1 ]
Aguirre, M. A. [1 ]
Sanchez-Pareja, I. [1 ]
Cerdo, T. [1 ]
Munoz-Barrera, L. [1 ]
Segui Azpilcueta, P. [2 ]
Merlo, C. [1 ]
Ortiz Buitrago, P. [1 ]
Ruiz, D. [3 ]
Abalos-Aguilera, M. C. [1 ]
Barbarroja Puerto, N. [3 ]
Ortega Castro, R. [1 ]
机构：
[1] Univ Cordoba, Rheumatol, Reina Sofia Hosp, IMIBIC, Cordoba, Spain
[2] Univ Cordoba, Radiol, Reina Sofia Hosp, IMIBIC, Cordoba, Spain
[3] Univ Cordoba, Med & Surg Sci, Reina Sofia Hosp, IMIBIC, Cordoba, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
D O I：
10.1136/annrheumdis-2023-eular.3620
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0293
引用
收藏
页码：388 / 389
页数：2
相关论文
共 50 条
  • [41] Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
    Arachchillage, D. R. J.
    Mackie, I. J.
    Efthymiou, M.
    Isenberg, D. A.
    Machin, S. J.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (07) : 1264 - 1273
  • [42] Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
    Arachchillage, D. Jayakody
    Mackie, I.
    Efthymiou, M.
    Isenberg, D.
    Machin, S.
    Cohen, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 10 - 10
  • [43] Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
    Arachchillage, D. J.
    Mackie, I
    Efthymiou, M.
    Isenberg, D.
    Machin, S.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 280 - 280
  • [44] Antiphospholipid antibodies: Evaluation of the thrombotic risk
    Devreese, Katrien M. J.
    THROMBOSIS RESEARCH, 2012, 130 : S37 - S40
  • [45] The value of thrombin generation analysis in thrombotic antiphospholipid syndrome patients on warfarin
    Efthymiou, M.
    Mackie, I. J.
    Lawrie, A. S.
    Machin, S. J.
    Cohen, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 38 - 39
  • [46] Arterial and/or veneous thrombotic events in Japanese patients with antiphospholipid syndrome.
    Kobayashi, S
    Hashimoto, H
    Akimoto, T
    Matsumoto, Y
    Miyasaka, N
    Koike, T
    Ohno, Y
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S367 - S367
  • [47] Thrombotic microangiopathy in patients with phosphatidylserine dependent antiprothrombin antibodies and antiphospholipid syndrome
    Kon, Y.
    Atsumi, T.
    Hagiwara, H.
    Furusaki, A.
    Kataoka, H.
    Horita, T.
    Yasuda, S.
    Amengual, O.
    Takao, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : 129 - 132
  • [48] Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
    Stanisavljevic, Natasa
    Stojanovich, Ljudmila
    Djokovic, Aleksandra
    Todic, Brankica
    Dopsaj, Violeta
    Saponjski, Jovica
    Saponjski, Dusan
    Markovic, Olivera
    Belizna, Cristina
    Zdravkovic, Marija
    Marisavljevic, Dragomir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [49] Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS
    Arias de la Rosa, Ivan
    Radin, Massimo
    Cecchi, Irene
    Rubini, Elena
    Perez-Sanchez, Carlos
    Angeles Aguirre, Maria
    Menegatti, Elisa
    Barbarroja, Nuria
    Collantes, Eduardo
    Sciascia, Savino
    Roccatello, Dario
    Lopez Pedrera, Chary
    RHEUMATOLOGY, 2019, 58 (10) : 1870 - 1872
  • [50] THROMBOTIC CEREBRAL ARTERIOPATHY IN PATIENTS WITH PRIMARY AND SECONDARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME
    MCCARTYFARID, GA
    LISTER, KA
    SHOLER, C
    BRUMBACH, R
    HUGHSON, MD
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R12 - R12
12345